Prognostic and Predictive Gene Expression Profiling (GEP) Markers Confirmed in Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Treated Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts)
van Vliet, Martin, Jasielec, Jagoda, Dytfeld, Dominik, Vij, Ravi, Dumee, Belinda, Bosman, Lizanne, deBest, Leonie C.M., Alonge, Mattina, Rosebeck, Shaun, Kandarpa, Malathi, McDonnell, Kathryn, Griffith, Kent A., van Beers, Erik H, Jakubowiak, Andrzej
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article